Virtual Medicinal Product (VMP) - Papaverine 30mg/1ml solution for injection vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Papaverine 30mg/1ml solution for injection vials | Start Date 31-01-2011 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular, Intravenous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intramuscular, solutioninjection.intravenous
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- G04BE02
- BNF Codes
-
- BNF code 07040500
| Code | Start Date | End Date |
|---|---|---|
| 18502211000001104 | 31-01-2011 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Papaverine hydrochloride | Based on Ingredient Substance | 30 mg | 1 ml |
Name
Papaverine hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
30.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMPapaverine
-
VMP(Current) Papaverine 30mg/1ml solution for inj...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 vial |